article thumbnail

[Panel Webinar] How to tap into pharma’s $100bn digital transformation opportunity

The Pharma Data

The pharma industry is witnessing a steep rise in the use of AI-driven solutions in early-stage drug discovery, deep-learning technologies for compound screening, and lead identification and automation enhancements in the lab. Next-generation digital technologies are having an immense impact on the drug discovery process.

article thumbnail

Resources, services, and tools

Broad Institute

Learn more Genome Analysis Toolkit (GATK) Industry standard for identifying SNPs and indels in germline DNA- and RNA-seq data. Learn more PRISM Rapid, high-throughput multiplexed compound screening in genomically characterized human cancer cell-line models.